Comments*

 
  • Events 

    Thursday, September 11, 2014 | 8:00 AM - 2:00 PM

    From Bacterial Immunity to Genome Editing: The 2014 Dr. Paul Janssen Award Symposium

    Featuring Award Winners: Emmanuelle Charpentier (Hannover Medical School, Helmholtz Centre for Infection Research, Umeå University) and Jennifer Doudna (University of California at Berkeley, Howard Hughes Medical Institute)

    Honor Drs. Emmanuelle Charpentier and Jennifer Doudna, recipients of the 2014 Dr. Paul Janssen Award for Biomedical Research.

    Monday, September 15, 2014 | 12:00 PM - 4:00 PM

    Click Chemistry in Biology and Medicine: New Developments and Strategies

    Keynote Speakers: Jim Paulson (The Scripps Research Institute), K. Barry Sharpless (The Scripps Research Institute)
    Speakers: Yimon Aye (Cornell University), David A. Spiegel (Yale University), Peng Wu (Albert Einstein College of Medicine)

    Click chemistry offers a reliable method for discovering chemical connectivity, with great potential in drug discovery and biomedical research. This symposium explores recent developments that offer new technologies for disease diagnosis and therapy.

    Friday, September 26, 2014 | 8:30 AM - 5:15 PM

    Early-Life Influences on Obesity: From Pre-Conception to Adolescence

    Speakers: Jane Wardle (University College London), Joel G. Ray (St. Michael's Hospitals), Julie Mennella (Monell Center), Linda M Szymanski (Johns Hopkins Medicine), Mark L. Wahlqvist (National Health Research Institutes), Mina Desai (University of California Los Angeles), Nancy F. Krebs (University of Colorado Denver), Rob A. Waterland (Baylor College of Medicine), Stephen Krawetz (Wayne State University School of Medicine)

    This conference will present how maternal nutrition, the microbiome, metabolic disorders, and fetal development affect obesity rates.

    Tuesday, September 30, 2014 | 8:30 AM - 5:00 PM

    Elucidating GPCR Functional Selectivity: Novel Opportunities for Drug Development

    Keynote Speaker: Nobel Laureate Robert J. Lefkowitz (Duke University Medical Center)
    Speakers: Bryan Roth (University of North Carolina at Chapel Hill School of Medicine), Terry Kenakin (University of North Carolina at Chapel Hill School of Medicine), Marc G. Caron (Duke University Medical Center), Laura Bohn (The Scripps Research Institute), Michael Ehlers (Pfizer), JoAnn Trejo (University of California-San Diego), Jonathan Violin (Trevena, Inc.)

    Hear academic, industry, basic and translational researchers, including Nobel Laureate Robert Lefkowitz (Duke University Medical Center) and discuss the development of functionally selective GPCR-biased ligands for CV and CNS disease drug discovery.

    Tuesday, October 28, 2014 | 8:30 AM - 5:00 PM

    Pharmacologic Resolution of Inflammation as a Novel Therapeutic Approach

    Speaker: Michael S. Conte (University of California-San Francisco, San Francisco, CA), Milan Fiala (David Geffen School of Medicine at UCLA, Los Angeles, CA), Gabrielle Fredman (Columbia University, New York, NY), Bruce Levy (Harvard University, Brigham and Women's Hospital, Boston, MA), Dipak Panigrahy (Beth Israel Deaconess Medical Center, Boston, MA), Mauro Perretti (William Harvey Research Institute, London, UK), Charles N. Serhan (Harvard University, New York, NY), Patricia J. Sime (University of Rochester School of Medicine, Rochester, NY), Rudy Tanzi (Massachusetts General Hospital, Charlestown, MA)

    Uncontrolled, chronic inflammation plays a key role in the progression of many diseases, and elucidation of biochemical pathways provides novel targets. This symposium reviews discoveries, approaches and opportunities for treatment and prevention.

  • Past Events

    Thursday, June 26, 2014 | 7:45 AM - 6:00 PM

    Demyelination and Remyelination: From Mechanism to Therapy

    Keynote Speaker: Robin Franklin (Wellcome Trust – MRC Cambridge Stem Cell Institute, University of Cambridge)

    This translational conference will highlight biological and clinical findings in myelin development, new techniques for brain imaging and for screening molecular targets, and novel therapeutics that promote remyelination.

    June 19 - 20, 2014

    Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy

    Keynote Speaker: Harold F. Dvorak (Beth Israel Deaconess Medical Center)

    This conference will examine issues in anti-angiogenic cancer therapy such as: (i) inherent / acquired resistance, (ii) immunomodulation (iii) enhanced invasiveness, and (iv) lack of validated predictive and prognostic biomarkers. Presentations, including a keynote lecture by Harold F. Dvorak, MD, will explore VEGF-dependent and alternative mechanisms of angiogenesis. Expert "point–counter point" debates will aim to resolve controversies regarding vascular normalization, treatment-induced metastasis, and the validity of hypertension as a physiological biomarker.

    Monday, June 9, 2014 | 10:00 AM - 3:15 PM

    2014 Ross Prize in Molecular Medicine: Advances in Immunomodulation

    Featured Speakers: John J. O'Shea (National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH), James P. Allison (The University of Texas MD Anderson Cancer Center), Louis M. Staudt (National Cancer Institute, National Institutes of Health), Charles A. Dinarello (University of Colorado at Denver)

    This symposium will honor Dr. John O'Shea, the recipient of the 2014 Ross Prize in Molecular Medicine, in recognition of his discoveries in immunology and cytokine biology.

    Tuesday, June 3, 2014 | 9:30 AM - 2:30 PM

    Chemical Biology Discussion Group Year-End Symposium

    Keynote Speaker: Michael Marletta (The Scripps Research Institute)

    The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. The year-end meeting features keynote speaker Michael Marletta of the Scripps Research Institute and a poster session.

  • Publications 

    Annals

    The Year in Evolutionary Biology

    Edited by Charles W. Fox (University of Kentucky) and Timothy A. Mousseau (University of South Carolina)

    This Annals volume features five in-depth review articles of diverse issues in evolutionary biology.

    Volume 1320

    eBriefing

    The Biology of Aging: Novel Drug Targets for Neurodegenerative Disease

    Organizers: Howard Fillit (Alzheimer's Drug Discovery Foundation), Kevin J. Lee (Lawrence Ellison Foundation), and Jennifer Henry (The New York Academy of Sciences)

    This eBriefing explores advances in the science of aging and in drug discovery for Alzheimer's and other neurodegenerative diseases.

    eBriefing

    HIV 2014: Science, Community, and Policy for Key Vulnerable Populations

    Organizers: Chris Beyrer (Johns Hopkins Bloomberg School of Public Health), Peter Godfrey-Faussett (UNAIDS), Ani Shakarishvili (UNAIDS), Yegor Voronin (Global HIV Vaccine Enterprise), and Jennifer Henry (The New York Academy of Sciences)

    The UNAIDS vision of zero new HIV infections, zero AIDS-related deaths, and zero discrimination calls for a global approach to HIV research and policy. This eBriefing focuses on improving outcomes for HIV in key vulnerable populations.

    Annals

    The Year in Immunology

    Edited by Noel R. Rose (Johns Hopkins University, Baltimore, Maryland)

    This sixth installment of The Year in Immunology series focuses on myeloid cells and inflammation.

    Volume 1319

  • Podcasts

    Podcast
    April 14, 2011

    The Diabetes-Gum Disease Connection

    Good oral hygiene helps prevent tooth decay and gum disease, but the health of your mouth may have a big impact on the rest of your body too—especially if you have diabetes.

    Download (11 MB, 13:03)
    Podcast
    September 10, 2010

    What Makes Us Wise?

    Can we all be wise old owls? Science journalist Stephen Hall and neuroscientist Andre Fenton dissect what we call wisdom, from the neurons in our brain, to the social constructs behind it.

    Download (22 MB, 00:42:32)
    Podcast
    August 27, 2010

    Better Brains

    Neuroscientist Richard Restak thinks with the right mental exercises, our brains can be much better. Today he teams with writer Susan Orlean to talk about our brainy potential.

    Download (35 MB, 00:54:21)
    Podcast
    August 13, 2010

    How Prosperity Evolves

    With our economy a shambles and our environment threatened, is there any reason to be optimistic about the future? Matt Ridley says there's scientific proof to say we should be.

    Download (33 MB, 00:51:28)
  • Webinar Archives

    Webinar Archive
    March 2, 2010

    Emerging Infectious Diseases in Response to Climate Change

    Climate and weather are important components of complex ecosystems, and with these changes, the dynamic balance between the living components of ecosystems is often disturbed. Experts in climate change, climate policy, emerging infectious diseases and public health discussed the relevant and pressing issues that we as a global community face as the planet's climate is altered.

    Webinar Archive
    February 23, 2010

    Metabotropic Glutamate Receptors: Translation from Discovery to Clinical Trials

    Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.

    Webinar Archive
    October 27, 2009

    Is Alzheimer's Disease Type 3 Diabetes?

    What is the connection between dysregulated neuronal insulin signaling and Alzheimer's disease? In a recent Academy webinar, some researchers argued that the neurodegenerative disease should be considered a type of diabetes.

    Webinar Archive
    April 28, 2009

    Protein Kinases: Structure-Guided Drug Discovery

    Protein kinases play a key role in almost every major pathway in eukaryotic cells. Structural approaches, including a new method called fragment-based drug design, are identifying potential targets against diseases including cancer.

  • Translational Medicine Initiative

    Macy FoundationThe Translational Medicine Initiative represents a three-year partnership between the New York Academy of Sciences and the Josiah Macy, Jr. Foundation to support the translation of basic science research into clinical applications.

    Learn more at www.nyas.org/TransMed.